NasdaqGM - Nasdaq Real Time Price USD

TransMedics Group, Inc. (TMDX)

121.58

-0.23

(-0.19%)

At close: May 16 at 4:00:01 PM EDT

117.55

-4.03

(-3.31%)

After hours: May 16 at 7:58:59 PM EDT

Earnings Estimates Moving Higher for TransMedics (TMDX): Time to Buy?

TransMedics (TMDX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks 3 days ago

TMDX
-0.19%
What Makes TransMedics (TMDX) a New Buy Stock

TransMedics (TMDX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks 3 days ago

TMDX
-0.19%
TransMedics Group (NASDAQ:TMDX) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

TransMedics Group, Inc. ( NASDAQ:TMDX ) just reported some strong earnings, and the market reacted accordingly with a...

Simply Wall St. 3 days ago

TMDX
-0.19%
2 Brilliant Stocks to Buy With $200 and Hold for 5 Years

Exact Sciences has helped increase colorectal cancer detection. TransMedics Group developed a revolutionary way to store organs before transplants. The company's Organ Care System (OCS) mimics the physiology of the human body, resulting in a higher usage rate for the organs it is approved for -- lungs, hearts, and kidneys -- than the traditional cold storage method.

Motley Fool 4 days ago

TMDX
-0.19%

EXAS
Is TransMedics Group, Inc. (TMDX) the Unstoppable Growth Stock to Invest in Now?

We recently published a list of 11 Unstoppable Growth Stocks to Invest in Now. In this article, we are going to take a look at where TransMedics Group, Inc. (NASDAQ:TMDX) stands against other unstoppable growth stocks to invest in now. BlackRock highlighted that the trade conflict between the US and China continues to cause major economic […]

Insider Monkey 5 days ago

TMDX
-0.19%

^RUT

BLK
TransMedics Group Stock Is Up 81% in 2025. Can It Climb Even Higher?

After a depressing 2024, TransMedics Group stock is surging in 2025. Shares of TransMedics Group (NASDAQ: TMDX) recently bounded higher in response to a first-quarter earnings report that was a lot better than investors were expecting. From the end of 2024 through the opening bell on Monday, May 12, TransMedics stock soared about 81%, and investors want to know if it can keep climbing.

Motley Fool 5 days ago

TMDX
-0.19%
Why TransMedics Group (TMDX) Is Among the Best Performing Healthcare Stocks to Buy Now

We recently published a list of 11 Best Performing Healthcare Stocks to Buy Now. In this article, we are going to take a look at where TransMedics Group, Inc. (NASDAQ:TMDX) stands against other best performing healthcare stocks to buy now. Trump’s Healthcare Executive Order Brings a Win On April 15, CNBC reported that President Trump’s […]

Insider Monkey 5 days ago

TMDX
-0.19%
TransMedics Group, Inc. (TMDX): A Bull Case Theory

We came across a bullish thesis on TransMedics Group, Inc. (TMDX) on Substack by Oliver | MMMT Wealth. In this article, we will summarize the bulls’ thesis on TMDX. TransMedics Group, Inc. (TMDX)’s share was trading at $95.81 as of May 7th. TMDX’s trailing and forward P/E were 89.54 and 63.29 respectively according to Yahoo Finance. TransMedics […]

Insider Monkey 8 days ago

TMDX
-0.19%
TransMedics Group First Quarter 2025 Earnings: Beats Expectations

TransMedics Group ( NASDAQ:TMDX ) First Quarter 2025 Results Key Financial Results Revenue: US$143.5m (up 48% from 1Q...

Simply Wall St. 8 days ago

TMDX
-0.19%
TransMedics surges, Rocket Lab USA drops, Toast guidance beat

TransMedics Group (TMDX) quarterly results beat on the top and bottom lines, sending the stock higher. Rocket Lab USA (RKLB) shares plunge after reporting a wider-than-expected quarterly loss. Toast (TOST) stock gains after the company's outlook beat estimates. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.

Yahoo Finance Video 9 days ago

TMDX
-0.19%

RKLB

TOST
Why TransMedics Stock Is Skyrocketing Today

TransMedics delivered revenue and net income growth of 48% and 111% in its first-quarter earnings. Shares of next-generation transplant technology platform TransMedics (NASDAQ: TMDX) were up 21% as of noon ET on Friday, according to data provided by S&P Global Market Intelligence. TransMedics reported first-quarter results that saw revenue balloon 48% and the company's net income margin rise from 13% a year ago to 18% today.

Motley Fool 9 days ago

TMDX
-0.19%
TMDX Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down

Increased organ utilization in liver and continued OCS adoption across both liver and heart boosted TransMedics' first-quarter 2025 performance.

Zacks 9 days ago

TMDX
-0.19%

ITGR

BSX
Former Highflier TransMedics Catapults To Seven-Month High On Liver-Driven Beat

TransMedics stock rocketed Friday after the company beat Wall Street's first-quarter expectations and hiked its 2025 revenue guidance.

Investor's Business Daily 9 days ago

TMDX
-0.19%
TransMedics Group Inc (TMDX) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ...

TransMedics Group Inc (TMDX) reports impressive revenue growth and improved margins, while addressing potential market and regulatory challenges.

GuruFocus.com 9 days ago

TMDX
-0.19%
Compared to Estimates, TransMedics (TMDX) Q1 Earnings: A Look at Key Metrics

The headline numbers for TransMedics (TMDX) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks 10 days ago

TMDX
-0.19%
TransMedics (TMDX) Tops Q1 Earnings and Revenue Estimates

TransMedics (TMDX) delivered earnings and revenue surprises of 141.38% and 16.17%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 10 days ago

TMDX
-0.19%
TransMedics: Q1 Earnings Snapshot

TMDX) on Thursday reported first-quarter profit of $25.7 million. On a per-share basis, the Andover, Massachusetts-based company said it had profit of 70 cents. The results topped Wall Street expectations.

Associated Press Finance 10 days ago

TMDX
-0.19%
TransMedics Reports First Quarter 2025 Financial Results

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter ended March 31, 2025.

PR Newswire 10 days ago

TMDX
-0.19%
Investing in TransMedics Group (NASDAQ:TMDX) five years ago would have delivered you a 433% gain

Buying shares in the best businesses can build meaningful wealth for you and your family. While not every stock...

Simply Wall St. 13 days ago

TMDX
-0.19%
Insights Into TransMedics (TMDX) Q1: Wall Street Projections for Key Metrics

Get a deeper insight into the potential performance of TransMedics (TMDX) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks 13 days ago

TMDX
-0.19%

Performance Overview

Return	TMDX	S&P 500 (^GSPC)
YTD	+95.00%	+1.30%
1-Year	-9.89%	+12.48%
3-Year	+341.31%	+48.66%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

TransMedics Group, Inc. (TMDX)

Earnings Estimates Moving Higher for TransMedics (TMDX): Time to Buy?

What Makes TransMedics (TMDX) a New Buy Stock

TransMedics Group (NASDAQ:TMDX) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

2 Brilliant Stocks to Buy With $200 and Hold for 5 Years

Is TransMedics Group, Inc. (TMDX) the Unstoppable Growth Stock to Invest in Now?

TransMedics Group Stock Is Up 81% in 2025. Can It Climb Even Higher?

Why TransMedics Group (TMDX) Is Among the Best Performing Healthcare Stocks to Buy Now

TransMedics Group, Inc. (TMDX): A Bull Case Theory

TransMedics Group First Quarter 2025 Earnings: Beats Expectations

TransMedics surges, Rocket Lab USA drops, Toast guidance beat

Why TransMedics Stock Is Skyrocketing Today

TMDX Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down

Former Highflier TransMedics Catapults To Seven-Month High On Liver-Driven Beat

TransMedics Group Inc (TMDX) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ...

Compared to Estimates, TransMedics (TMDX) Q1 Earnings: A Look at Key Metrics

TransMedics (TMDX) Tops Q1 Earnings and Revenue Estimates

TransMedics: Q1 Earnings Snapshot

TransMedics Reports First Quarter 2025 Financial Results

Investing in TransMedics Group (NASDAQ:TMDX) five years ago would have delivered you a 433% gain

Insights Into TransMedics (TMDX) Q1: Wall Street Projections for Key Metrics

Performance Overview